These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 17121210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin degludec. Uncertainty over cardiovascular harms.
    Prescrire Int; 2014 Jun; 23(150):149. PubMed ID: 25121146
    [Abstract] [Full Text] [Related]

  • 4. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE.
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [Abstract] [Full Text] [Related]

  • 5. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul 03; 48(1238):54-5. PubMed ID: 16841022
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.
    Monami M, Marchionni N, Mannucci E.
    Diabetes Res Clin Pract; 2008 Aug 03; 81(2):184-9. PubMed ID: 18495286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Long-acting insulin analogs: progressing slowly].
    Holleman F, Hoekstra JB.
    Ned Tijdschr Geneeskd; 2004 Aug 21; 148(34):1668-9. PubMed ID: 15453117
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH, Nattrass M, Pieber TR.
    Diabetes Metab Res Rev; 2007 Sep 21; 23(6):441-54. PubMed ID: 17668418
    [Abstract] [Full Text] [Related]

  • 13. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Sep 21; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 14. Insulin detemir: a new basal insulin analogue.
    Soran H, Younis N.
    Diabetes Obes Metab; 2006 Jan 21; 8(1):26-30. PubMed ID: 16367879
    [Abstract] [Full Text] [Related]

  • 15. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ.
    Prim Care Diabetes; 2010 Apr 21; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [Abstract] [Full Text] [Related]

  • 16. Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemir.
    O'goshi K, Serup J, Blaaholm B, Thomsen HK, Rossing P, Tarnow L.
    Skin Res Technol; 2011 Nov 21; 17(4):411-9. PubMed ID: 21729174
    [Abstract] [Full Text] [Related]

  • 17. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L, Koenen C, Weng W, Selam JL.
    Diabetes Obes Metab; 2007 Nov 21; 9(6):902-13. PubMed ID: 17924873
    [Abstract] [Full Text] [Related]

  • 18. An update on the long-acting insulin analogue glargine.
    Thisted H, Johnsen SP, Rungby J.
    Basic Clin Pharmacol Toxicol; 2006 Jul 21; 99(1):1-11. PubMed ID: 16867163
    [Abstract] [Full Text] [Related]

  • 19. Insulin analogs versus human insulin in type 2 diabetes.
    Migdalis IN.
    Diabetes Res Clin Pract; 2011 Aug 21; 93 Suppl 1():S102-4. PubMed ID: 21864739
    [Abstract] [Full Text] [Related]

  • 20. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K, Dornhorst A, Sreenan S.
    Curr Med Res Opin; 2009 Nov 21; 25(11):2601-8. PubMed ID: 19739940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.